ANIP

ANI PHARMACEUTICALS INC

ANIP·00182C103·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist

ANIP (ANI PHARMACEUTICALS INC) is held by 145 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($211.3M), VANGUARD CAPITAL MANAGEMENT LLC ($63.3M), STATE STREET CORP ($59.3M). Net institutional sentiment: Mixed.

145
Holders
(12 Elite)
$1.3B
Total Value
54% (149)
Consensus
81 buying - 68 selling
13F: Insider & Congress:
ANIPSmart Money Verdict
View all
Held by 145 funds
12 elite
Who's Trading
InsiderCMCook MeredithSell $41KJul 13, 2026
InsiderCPCAREY STEPHEN P.Sell $240KJun 29, 2026
InsiderCMCook MeredithSell $41KJun 12, 2026
InsiderCMCook MeredithSell $39KMay 13, 2026
InsiderRARowland Thomas AndrewSell $36KMay 12, 2026
InsiderCMCook MeredithSell $39KApr 13, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
InsiderMCMutz ChristopherSell $227KMar 13, 2026
InsiderCMCook MeredithSell $36KMar 13, 2026
ActivistICIntegrated Core Strategies (US) LLC0.2%Nov 13, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
2.7M(+3.2%)$211.3M0.0%+46.74%
32
New
823,064$63.3M0.0%+7.84%
41
Increased
771,587(+6.1%)$59.3M0.0%+41.91%
31
Increased
592,013(+9.7%)$45.5M0.0%+6.75%
32
Increased
564,360(+19.3%)$43.4M0.0%-5.52%
34
Increased
531,190(+8.9%)$40.8M0.0%+76.74%
32
Increased
497,702(+230.1%)$38.3M0.0%+10.66%
47
Increased
489,201(+2.5%)$37.6M0.0%+50.47%
30
Increased
402,357(+3.9%)$30.9M0.0%+21.22%
30
New
375,965$28.9M0.0%+7.84%
40
Increased
327,276(+3.3%)$25.2M0.1%+108.97%
30
Increased
324,349(+70.9%)$24.9M0.0%+22.57%
43
Decreased
319,675(-18.6%)$24.6M0.0%+19.46%
0
Decreased
287,563(-3.9%)$22.1M0.0%+3.34%
0
Increased
270,262(+0.1%)$20.8M0.0%+69.69%
28
Increased
254,230(+80.2%)$19.6M0.1%+7.65%
52
Increased
237,225(+5.9%)$18.2M0.0%+30.82%
30
Decreased
234,288(-6.9%)$18M0.0%+35.35%
0
Increased
230,072(+4.9%)$17.7M0.0%+41.55%
30
Increased
220,224(+45.6%)$16.9M0.1%+18.13%
38

Showing 1-20 of 159

1 / 8

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used